88 优惠券
2020年3月1日到期。满 200 元可用
立即使用
立即使用

首页>演讲嘉宾> MariondeJong更新时间:2015-10-31

MariondeJong

Marion de Jong, Ph.D., is a Professor of Nuclear Biology at the Departments of Nuclear Medicine and Radiology at Erasmus MC in Rotterdam/The Netherlands. She got her PhD degree in 1993 at the Erasmus MC. She is the chair of the SPECTRIM group in molecular imaging and therapy, she was promoted as professor in 2006. Marion de Jong has (co)published more than 300 peer-reviewed papers in international journals (H-Index is 54), holds several patents, obtained many grants and she, as well as her team members, received numerous awards. She was promotor (supervisor) of > 30 past and current PhD students. She is chair of the Translational Molecular Imaging Committee of the European Association of Nuclear Medicine (EANM), member of the Molecular Imaging Committee for the European Society of Radiology, Vice chair of the Nantes Cyclotron (Arronax) Scientific Committee, Member of the national VIDI committee and Chair of the Expert Committee of the Animal Imaging Facility at Erasmus MC. Her major scientific interests include: 1) Translational imaging and radionuclide therapy of tumours and other lesions using theranostic radiopharmaceuticals, with a focus on radiolabelled peptides, and 2) Translational molecular imaging of lesions with focus on nuclear imaging, also in combination with CT, optical imaging and MRI. Selective receptor-targeting radiopeptides have emerged as a very important class of radiopharmaceuticals for molecular imaging and therapy of tumours that overexpress peptide receptors on the cell membrane. After such peptides labeled with diagnostic radionuclides bind to their receptors, they allow visualization of receptor-expressing tumors non-invasively. Peptides labeled with therapeutic beta- or alpha-particle emitters can eradicate receptor-expressing tumors. Erasmus MC has been a pioneer in this field and is still at the forefront of the research field. In the clinic we imaged over 5000 patients using radiolabelled somatostatin analogues, whereas over 1500 treatments were given. Our efforts now concentrate on widening the therapeutic window by combination therapy, increasing the tumour radiation dose and/or decreasing the dose to the normal, healthy, organs. Finally, we aim at curing these now incurable metastasized cancers. To enlarge the panel of tumours to be imaged and treated, we also design and evaluate analogues of other peptides, including bombesin, CCK, and neurotensin analogues that bind to their receptors in a variety of different tumours.

活动家是第三方嘉宾邀约平台。可根据演讲议题、会议日期、活动预算等要求,为您提供该领域内专业嘉宾演讲邀约服务。您可准备好活动信息后,联系客服电话:18911802888(工作日9时至18时,仅邀约嘉宾出席活动,其他需求勿扰)

您可能感兴趣的嘉宾 最新入驻
换一批
福建盈科创业投资有限公司董事长钱明飞照片
钱明飞

福建盈科创业投资有限公司

董事长

泉州豪威名酒有限公司董事长吴玲玲照片
吴玲玲

泉州豪威名酒有限公司

董事长

福建龙马环卫装备股份有限公司董事长张桂丰照片
张桂丰

福建龙马环卫装备股份有限公司

董事长

第一创业证券股份有限公司董事长刘学民照片
刘学民

第一创业证券股份有限公司

董事长

富临精工董事长谭建伟照片
谭建伟

富临精工

董事长

StellantisGlobal Responsible of Casting Light Alloy team Jacopo照片
Jacopo

Stellantis

Global Responsible of Casting Light Alloy team

VerdoxCEOBrian照片
Brian

Verdox

CEO

南山铝业板带事业部铝箔工艺副总工/可持续发展小组副组长(兼)刘玥照片
刘玥

南山铝业板带事业部

铝箔工艺副总工/可持续发展小组副组长(兼)

carboneer Ltd.CEOSimon照片
Simon

carboneer Ltd.

CEO

西门子人力资源执行副总裁兼可持续发展负责人马清照片
马清

西门子

人力资源执行副总裁兼可持续发展负责人

热门嘉宾推荐
优客工场创始人/董事长毛大庆照片
毛大庆

优客工场

创始人/董事长

博得世纪管理顾问机构董事长周志轩照片
周志轩

博得世纪管理顾问机构

董事长

真格基金创始人徐小平照片
徐小平

真格基金

创始人

中国工程院院士邬贺铨照片
邬贺铨

中国工程院

院士

格力集团董事长董明珠照片
董明珠

格力集团

董事长

MariondeJong出席会议日程